<format type="yaml">{report_id: string, report_date: date, patient_details: {patient_id: string, age_at_reaction: number optional, gender: string, relevant_history: list[string]}, suspected_drugs: list[{drug_name: string, drug_class: string optional, dosage: string, route_of_administration: string, start_date: date, end_date: date optional, indication_for_use: string}], adverse_reactions: list[{symptom_name: string, onset_date: date, severity: string, outcome: string, intervention_required: boolean, intervention_details: string optional}], causality_assessment: {naranjo_score: number optional, assessment_conclusion: string, dechallenge_rechallenge: string}, reporting_facility: string, reporter_type: string, notes: string optional}</format> <data>PHARMACOVIGILANCE CASE REPORT - CONFIDENTIAL
Report Identifier: ADR-2024-489
Date of Submission: 2024-12-07

This report was submitted by a Pharmacist from Henry-Shaw Medical Center concerning patient ANON-PX-6394. The subject is an adult other with a significant medical history including type 2 diabetes, chronic kidney disease, migraines, seasonal allergies. The facility's standard operating procedure for ADR reporting was followed, and all patient data has been anonymized. The patient chart was reviewed for comorbidities. 

Current medication review revealed the following suspected agent(s): Ibuprofen (NSAID) administered via the Intramuscular route at a dosage of 184mg, initiated on 2024-10-30 for Pain and inflammation and discontinued on 2024-12-06.

On approximately 2024-11-29, the patient began to manifest an adverse event. The primary symptoms noted in the clinical log were Somnolence, Maculopapular Rash, Headache. The Somnolence was classified as Mild in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Unknown'. The Maculopapular Rash was classified as Moderate in severity. This necessitated clinical intervention. The documented action was: Prescribed least and advised west. The current patient status regarding this symptom is 'Recovered'. The Headache was classified as Severe in severity. No specific therapeutic intervention was required. The current patient status regarding this symptom is 'Recovered'. 

CAUSALITY ASSESSMENT:
An evaluation of causality was performed. The assessment concluded the relationship was 'Probable'. Dechallenge/Rechallenge status was noted as: 'Rechallenge not performed'. The on-site pharmacist concurred with the assessment during a routine case review. 

Reporter's Narrative Summary: Question your high recently letter brother best left. Few relationship let million reach well. Character station attorney consider force specific painting.</data>
report_id: ADR-2024-489
report_date: '2024-12-07'
patient_details:
  patient_id: ANON-PX-6394
  gender: Other
  relevant_history:
  - type 2 diabetes
  - chronic kidney disease
  - migraines
  - seasonal allergies
suspected_drugs:
- drug_name: Ibuprofen
  dosage: 184mg
  route_of_administration: Intramuscular
  start_date: '2024-10-30'
  indication_for_use: Pain and inflammation
  drug_class: NSAID
  end_date: '2024-12-06'
adverse_reactions:
- symptom_name: Somnolence
  onset_date: '2024-11-29'
  severity: Mild
  outcome: Unknown
  intervention_required: false
- symptom_name: Maculopapular Rash
  onset_date: '2024-11-29'
  severity: Moderate
  outcome: Recovered
  intervention_required: true
  intervention_details: Prescribed least and advised west.
- symptom_name: Headache
  onset_date: '2024-11-29'
  severity: Severe
  outcome: Recovered
  intervention_required: false
causality_assessment:
  assessment_conclusion: Probable
  dechallenge_rechallenge: Rechallenge not performed
reporting_facility: Henry-Shaw Medical Center
reporter_type: Pharmacist
notes: Question your high recently letter brother best left. Few relationship let
  million reach well. Character station attorney consider force specific painting.
